Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Diagnostic Contract Manufacturing Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for contract manufacturing within the diagnostics sector has experienced significant expansion. Projections indicate a rise from $35.81 billion in 2025 to $40.95 billion by 2026, reflecting a compound annual growth rate of 14.4%. Key factors contributing to this expansion historically include the substantial financial investment needed for in-house production capabilities, the intricate regulatory landscape, an increasing number of new diagnostic product introductions, a need for adaptable manufacturing processes, and the increasing interconnectedness of global supply chains.

The market for diagnostic contract manufacturing is poised for significant expansion in the upcoming years, projected to reach $66.08 billion by 2030 with a compound annual growth rate of 12.7%. This anticipated surge is fueled by advancements in diagnostic technologies, the need for swift production scaling, increased automation, the broadening of manufacturing operations across regions, and a strong emphasis on establishing robust supply chains. Key developments expected during this period include a greater reliance on outsourced manufacturing for diagnostics, a growing need for services that adhere to regulatory standards, the expansion of comprehensive contract development and manufacturing organization (CDMO) services, a heightened focus on achieving cost efficiencies and production scalability, and the integration of automated and intelligent manufacturing methodologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16032&type=smp

#Diagnostic Contract Manufacturing Market Demand Drivers Creating New Revenue Opportunities

The diagnostic contract manufacturing sector is poised for expansion, largely fueled by a heightened emphasis on preventive healthcare strategies. This approach to healthcare prioritizes actions aimed at averting the onset or progression of illnesses, injuries, or diseases, driven by escalating medical expenses, evolving healthcare objectives, a surge in long-term health conditions, and an aging populace. Diagnostic contract manufacturers play a crucial role in advancing this preventive agenda by supplying vital diagnostic instruments and assays, delivering tailored manufacturing services, upholding stringent quality and regulatory standards, facilitating production scaling, and providing economical solutions for both disease avoidance and timely detection. A notable indicator of this trend is that, as reported by Eurostat in October 2025, preventive care constituted the second-largest allocation of EU healthcare expenditure in 2023, accounting for 3.7% of the total, with the Netherlands dedicating the highest proportion (5.2%) and Malta the least (0.9%). Consequently, the growing importance of preventive healthcare is a significant catalyst for the diagnostic contract manufacturing market’s growth.

Diagnostic Contract Manufacturing Market Segmentation And Category Breakdown

The diagnostic contract manufacturing market covered in this report is segmented –

1) By Service: Device Development And Manufacturing Services, Quality Management Services, Packaging And Assembly Services, Other Services

2) By Application: In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Applications

3) By End User: Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, Other End Users

Subsegments:

1) By Device Development And Manufacturing Services: Product Design And Prototyping, Regulatory Affairs And Compliance, Manufacturing And Assembly, Testing And Validation

2) By Quality Management Services: Quality Control And Assurance, Auditing And Inspection Services, Risk Management, Compliance And Certification Support

3) By Packaging And Assembly Services: Primary Packaging, Secondary Packaging, Sterilization Services, Custom Packaging Solutions

4) By Other Services: Supply Chain Management, Inventory Management, Logistics And Distribution, Aftermarket Services

Diagnostic Contract Manufacturing Market Trends Driving Strategic Industry Expansion

Leading entities within the diagnostic contract manufacturing sector are prioritizing the creation of sophisticated offerings, exemplified by integrated chemiluminescence immunoassay (CLIA) systems, aimed at elevating assay precision, optimizing manufacturing processes, and catering to the expanding need for high-volume and accurate diagnostic evaluations. This comprehensive CLIA approach signifies a departure from conventional fragmented production; instead, a contract manufacturer delivers a complete package encompassing essential raw materials, reagent formulation, versatile open-system analyzers, and scaled manufacturing capacity. Illustrating this trend, Fapon Biotech Inc., a Chinese provider of in-vitro diagnostic solutions, unveiled its unified chemiluminescence solution strategy in April 2023. This initiative included the introduction of compact and large-scale open-system CLIA analyzers, specifically the Shine i1000 and Shine i2000 models, complemented by an extensive selection of over 100 CLIA reagents designed for detecting biomarkers associated with oncology, cardiovascular conditions, infectious diseases, thyroid function, and inflammatory processes. This all-encompassing solution is engineered to empower diagnostic firms by expediting the introduction of new products and broadening their testing capabilities, further benefiting from superior raw material procurement, adaptable reagent development assistance, diminished per-test expenses, and enhanced compliance with regional manufacturing regulations.

Diagnostic Contract Manufacturing Market Competitive Analysis Of Major Industry Participants

Major companies operating in the diagnostic contract manufacturing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Jabil Inc., Flex Ltd., Becton Dickinson and Company (BD), Sekisui Diagnostics LLC, Sanmina Corporation, Celestica Inc., Nipro Medical Corporation, Philips-Medisize Corporation, Plexus Corp, West Pharmaceutical Services Inc., Benchmark Electronics Inc., Bio-Rad Laboratories, QIAGEN N.V., Kimball Electronics Inc., Integer Holdings Corporation, Bio-Techne Corporation, Nolato AB, Nova Biomedical Corporation, Meridian Bioscience Inc., Fujirebio Inc., Biokit S.A., Invetech Pty. Ltd., KMC Systems, Savyon Diagnostics Ltd., Prestige Diagnostics U.K. Ltd., Cenogenic Corporation, Avioq Inc.

Access The Complete Diagnostic Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/diagnostic-contract-manufacturing-global-market-report

Diagnostic Contract Manufacturing Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the diagnostic contract manufacturing market in 2025. The regions covered in the diagnostic contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model